
Binu Thomas
Examiner (ID: 12732, Phone: (571)270-7684 , Office: P/1717 )
| Most Active Art Unit | 1717 |
| Art Unit(s) | 1717 |
| Total Applications | 891 |
| Issued Applications | 585 |
| Pending Applications | 109 |
| Abandoned Applications | 239 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8324522
[patent_doc_number] => 20120196936
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'Composition Comprising S-Allyl-L-Cysteine as Active Ingredient for Preventing or Treating Gastrointestinal Disorders'
[patent_app_type] => utility
[patent_app_number] => 13/497421
[patent_app_country] => US
[patent_app_date] => 2010-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 8400
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497421
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/497421 | Composition Comprising S-Allyl-L-Cysteine as Active Ingredient for Preventing or Treating Gastrointestinal Disorders | Sep 19, 2010 | Abandoned |
Array
(
[id] => 7756783
[patent_doc_number] => 20120028931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-02
[patent_title] => 'HETEROCYCLIC M-GLU5 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 12/882169
[patent_app_country] => US
[patent_app_date] => 2010-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47986
[patent_no_of_claims] => 63
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20120028931.pdf
[firstpage_image] =>[orig_patent_app_number] => 12882169
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/882169 | HETEROCYCLIC M-GLU5 ANTAGONISTS | Sep 13, 2010 | Abandoned |
Array
(
[id] => 5993563
[patent_doc_number] => 20110015216
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-20
[patent_title] => 'Solid Pharmaceutical Dosage Form'
[patent_app_type] => utility
[patent_app_number] => 12/880781
[patent_app_country] => US
[patent_app_date] => 2010-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5805
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20110015216.pdf
[firstpage_image] =>[orig_patent_app_number] => 12880781
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/880781 | Solid pharmaceutical dosage form | Sep 12, 2010 | Issued |
Array
(
[id] => 6134528
[patent_doc_number] => 20110008430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-13
[patent_title] => 'Solid Pharmaceutical Dosage Form'
[patent_app_type] => utility
[patent_app_number] => 12/880766
[patent_app_country] => US
[patent_app_date] => 2010-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5804
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0008/20110008430.pdf
[firstpage_image] =>[orig_patent_app_number] => 12880766
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/880766 | Solid pharmaceutical dosage form | Sep 12, 2010 | Issued |
Array
(
[id] => 6196672
[patent_doc_number] => 20110028430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-02-03
[patent_title] => 'INJECTABLE VISCOUS MEDICINAL PREPARATION COMPRISING ETHANOL AND AN X-RAY OPAQUE FAT-SOLUBLE COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 12/876474
[patent_app_country] => US
[patent_app_date] => 2010-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2007
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0028/20110028430.pdf
[firstpage_image] =>[orig_patent_app_number] => 12876474
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/876474 | INJECTABLE VISCOUS MEDICINAL PREPARATION COMPRISING ETHANOL AND AN X-RAY OPAQUE FAT-SOLUBLE COMPOUND | Sep 6, 2010 | Abandoned |
Array
(
[id] => 9140321
[patent_doc_number] => 08580783
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-11-12
[patent_title] => '[1,2,4]triazolo [1,5-c]pyrimidine derivatives as Hsp90 modulators'
[patent_app_type] => utility
[patent_app_number] => 13/394255
[patent_app_country] => US
[patent_app_date] => 2010-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22025
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13394255
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/394255 | [1,2,4]triazolo [1,5-c]pyrimidine derivatives as Hsp90 modulators | Sep 2, 2010 | Issued |
Array
(
[id] => 6026580
[patent_doc_number] => 20110054036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'COMPOSITION AND METHOD FOR IRRIGATION OF A PREPARED DENTAL ROOT CANAL'
[patent_app_type] => utility
[patent_app_number] => 12/868457
[patent_app_country] => US
[patent_app_date] => 2010-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4088
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0054/20110054036.pdf
[firstpage_image] =>[orig_patent_app_number] => 12868457
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/868457 | Composition and method for irrigation of a prepared dental root canal | Aug 24, 2010 | Issued |
Array
(
[id] => 8612757
[patent_doc_number] => 20130018069
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'SUSTAINED RELEASE DELIVERY SYSTEMS FOR THE PREVENTION AND TREATMENT OF HEAD AND NECK CANCERS'
[patent_app_type] => utility
[patent_app_number] => 13/391756
[patent_app_country] => US
[patent_app_date] => 2010-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7617
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13391756
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/391756 | Sustained release delivery systems for the prevention and treatment of head and neck cancers | Aug 24, 2010 | Issued |
Array
(
[id] => 6149988
[patent_doc_number] => 20110021583
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-27
[patent_title] => 'ENHANCED TRANSMUCOSAL COMPOSITION AND DOSAGE FORM'
[patent_app_type] => utility
[patent_app_number] => 12/860978
[patent_app_country] => US
[patent_app_date] => 2010-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 13686
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0021/20110021583.pdf
[firstpage_image] =>[orig_patent_app_number] => 12860978
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/860978 | ENHANCED TRANSMUCOSAL COMPOSITION AND DOSAGE FORM | Aug 22, 2010 | Abandoned |
Array
(
[id] => 8324442
[patent_doc_number] => 20120196853
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-08-02
[patent_title] => 'Novel Quinoline-Hepcidine Antagonists'
[patent_app_type] => utility
[patent_app_number] => 13/390785
[patent_app_country] => US
[patent_app_date] => 2010-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 43
[patent_figures_cnt] => 43
[patent_no_of_words] => 17726
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13390785
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/390785 | Novel Quinoline-Hepcidine Antagonists | Aug 18, 2010 | Abandoned |
Array
(
[id] => 5977829
[patent_doc_number] => 20110071124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-24
[patent_title] => 'Compounds that Inhibit Production of sAPPB and AB and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/858837
[patent_app_country] => US
[patent_app_date] => 2010-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 96
[patent_figures_cnt] => 96
[patent_no_of_words] => 17290
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0071/20110071124.pdf
[firstpage_image] =>[orig_patent_app_number] => 12858837
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/858837 | Compounds that Inhibit Production of sAPPB and AB and Uses Thereof | Aug 17, 2010 | Abandoned |
Array
(
[id] => 8503182
[patent_doc_number] => 20120302590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'METHODS AND COMPOSITIONS TO PREVENT ADDICTION'
[patent_app_type] => utility
[patent_app_number] => 13/389959
[patent_app_country] => US
[patent_app_date] => 2010-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 20281
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13389959
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/389959 | METHODS AND COMPOSITIONS TO PREVENT ADDICTION | Aug 12, 2010 | Abandoned |
Array
(
[id] => 8313644
[patent_doc_number] => 20120190668
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'ENHANCEMENT OF CELLULAR TRANSPLANTATION USING SMALL MOLEUCLE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY'
[patent_app_type] => utility
[patent_app_number] => 13/384760
[patent_app_country] => US
[patent_app_date] => 2010-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29133
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13384760
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/384760 | ENHANCEMENT OF CELLULAR TRANSPLANTATION USING SMALL MOLEUCLE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY | Aug 11, 2010 | Abandoned |
Array
(
[id] => 8653229
[patent_doc_number] => 08372978
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-12
[patent_title] => 'Salts of methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate'
[patent_app_type] => utility
[patent_app_number] => 12/851267
[patent_app_country] => US
[patent_app_date] => 2010-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 11641
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12851267
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/851267 | Salts of methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate | Aug 4, 2010 | Issued |
Array
(
[id] => 8313727
[patent_doc_number] => 20120190751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'COMPOUNDS FOR TREATMENTS OF INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 13/388174
[patent_app_country] => US
[patent_app_date] => 2010-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 9242
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13388174
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/388174 | COMPOUNDS FOR TREATMENTS OF INFLAMMATION | Jul 29, 2010 | Abandoned |
Array
(
[id] => 6000638
[patent_doc_number] => 20110117070
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-05-19
[patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING HEADACHE'
[patent_app_type] => utility
[patent_app_number] => 12/844700
[patent_app_country] => US
[patent_app_date] => 2010-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6036
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0117/20110117070.pdf
[firstpage_image] =>[orig_patent_app_number] => 12844700
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/844700 | COMPOSITIONS AND METHODS FOR TREATING HEADACHE | Jul 26, 2010 | Abandoned |
Array
(
[id] => 8313634
[patent_doc_number] => 20120190648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'FLUORINATED CYCLOPROPANE ANALOGS OF GLUTAMIC ACID'
[patent_app_type] => utility
[patent_app_number] => 13/386162
[patent_app_country] => US
[patent_app_date] => 2010-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15656
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13386162
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/386162 | FLUORINATED CYCLOPROPANE ANALOGS OF GLUTAMIC ACID | Jul 22, 2010 | Abandoned |
Array
(
[id] => 6007139
[patent_doc_number] => 20110059170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'METHODS FOR ADMINISTERING WEIGHT LOSS MEDICATIONS'
[patent_app_type] => utility
[patent_app_number] => 12/838364
[patent_app_country] => US
[patent_app_date] => 2010-07-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12514
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059170.pdf
[firstpage_image] =>[orig_patent_app_number] => 12838364
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/838364 | Methods for administering weight loss medications | Jul 15, 2010 | Issued |
Array
(
[id] => 6449169
[patent_doc_number] => 20100280125
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'MEDICINAL AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/834627
[patent_app_country] => US
[patent_app_date] => 2010-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6259
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0280/20100280125.pdf
[firstpage_image] =>[orig_patent_app_number] => 12834627
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/834627 | MEDICINAL AGENT | Jul 11, 2010 | Abandoned |
Array
(
[id] => 8312557
[patent_doc_number] => 20120189579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-26
[patent_title] => 'SUBSTITUTED PYRROLIDINONE AS INHIBITORS OF HEPATITIS C NS5B POLYMERASE, THE PHARMACEUTICAL COMPOSITION THEREOF AND THEIR THERAPEUTIC USE'
[patent_app_type] => utility
[patent_app_number] => 13/383042
[patent_app_country] => US
[patent_app_date] => 2010-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19146
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13383042
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/383042 | SUBSTITUTED PYRROLIDINONE AS INHIBITORS OF HEPATITIS C NS5B POLYMERASE, THE PHARMACEUTICAL COMPOSITION THEREOF AND THEIR THERAPEUTIC USE | Jul 8, 2010 | Abandoned |